Young‐Joon Surh

34.0k citations

411 papers · 27.8k indexed · 6 hit papers · h-index 81

Impact in

Biochemistry top 0.02%
- Phytochemicals and Antioxidant Activities
Pharmacology top 0.01%
- Ginger and Zingiberaceae research
- Inflammatory mediators and NSAID effects
- Pharmacological Effects of Natural Compounds

Papers in

Geriatrics and Gerontology 27
- Sirtuins and Resveratrol in Medicine 27
Toxicology 21

Co-authors: Joydeb Kumar Kundu Hye‐Kyung Na Kyung‐Soo Chun Young‐Nam Cha Kwang-Kyun Park Young‐Sam Keum Do‐Hee Kim Jeong‐Sang Lee
Journals: Cancer Letters (22 papers)Biochemical Pharmacology (22 papers)Annals of the New York Academy of Sciences (19 papers)Carcinogenesis (19 papers)Mutation research. Fundamental and molecular mechanisms of mutagenesis (16 papers)
Partner nations: South Korea United States Puerto Rico

In The Last Decade

Young‐Joon Surh

408 papers receiving 26.8k citations

Hit Papers

6 papers align trajectories log scale

A protective role of nuclear factor-erythroid 2-related factor-2 (Nrf2) in inflammatory disorders 2009 · 596 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2009 Mutation research. Fundamental and molecular mechanisms of mutagenesis
2008 Mutation Research/Reviews in Mutation Research
2008 Planta Medica
2003 Nature reviews. Cancer
2001 Mutation research. Fundamental and molecular mechanisms of mutagenesis
1999 Mutation research. Fundamental and molecular mechanisms of mutagenesis

Peers

Countries citing papers authored by Young‐Joon Surh

Since Specialization

Citations

This map shows the geographic impact of Young‐Joon Surh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Young‐Joon Surh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Young‐Joon Surh more than expected).

Fields of papers citing papers by Young‐Joon Surh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Young‐Joon Surh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Young‐Joon Surh. The network helps show where Young‐Joon Surh may publish in the future.

Co-authors

The 25 scholars most cited alongside Young‐Joon Surh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Young‐Joon Surh Line = papers co-authored together Young‐Joon Surh links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Curcumin and EGCG combined formulation in nanostructured lipid carriers for anti-aging applications International Journal of Pharmaceutics X ·Chidchanok Prathumwon, Songyot Anuchapreeda, Kanokwan Kiattisin, Pawaret Panyajai, Panikchar Wichayapreechar, Young‐Joon Surh, Chadarat Ampasavate	2025	2
2	STAT3 Stabilizes IKKα Protein through Direct Interaction in Transformed and Cancerous Human Breast Epithelial Cells Cancers ·Young-Il Hahn, Soma Saeidi, Su‐Jung Kim, Se-Young Park, Na‐Young Song, Jie Zheng, Do-Hee Kim, Han‐Byoel Lee, Wonshik Han, Dong‐Young Noh, Hye-Kyung Na, Young‐Joon Surh	2020	14
3	Perilla extract potentiates efferocytosis by macrophages: Implications for resolution of inflammation Journal of Food Bioactives ·Seung Hyeon Kim, Deung-Dae Park, Won‐Ki Kim, Takuma Shio, Jun Takanari, Takehito Miura, Young‐Joon Surh	2020	1
4	Interaction of Nrf2 with dimeric STAT3 induces IL-23 expression: Implications for breast cancer progression Cancer Letters ·Su‐Jung Kim, Soma Saeidi, Nam-Chul Cho, Seung Hyeon Kim, Han‐Byoel Lee, Wonshik Han, Dong‐Young Noh, Young‐Joon Surh	2020	22
5	Nuclear Factor Erythroid-Derived 2-Like 2-Induced Reductive Stress Favors Self-Renewal of Breast Cancer Stem-Like Cells via the FoxO3a-Bmi-1 Axis Antioxidants and Redox Signaling ·Do‐Hee Kim, Jeong‐Hoon Jang, Ok‐Seon Kwon, Hyuk‐Jin Cha, H Y Youn, Kyung‐Soo Chun, Young‐Joon Surh	2019	40
6	Abstracts from the 2nd International Symposium on Phytochemicals in Medicine and Food (2-ISPMF) Chinese Medicine ·Zhangjing Zhang, Chunming Wang, Yitao Wang, Bernhard Hennig, Francesca Giampieri, Tamara Y. Forbes‐Hernández, Sadia Afrin, Danila Cianciosi, Massimiliano Gasparrini, Maurizio Battino, Young‐Joon Surh, Nuria Chinchilla, Guillermo A. Guerrero‐Vásquez, Alexandra G. Durán, Mariola Macías, Juan Manuel Sánchez Calvo, Rosa M. Varela, José M. G. Molinillo, Francisco A. Macı́as, Alexander Panossian, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	2018	2
7	Amelioration of UVB-induced oxidative stress and inflammation in fat-1 transgenic mouse skin Biochemical and Biophysical Research Communications ·Hye-Won Yum, Seong Hoon Kim, Jing X. Kang, Young‐Joon Surh	2018	10
8	Nrf2 Mutagenic Activation Drives Hepatocarcinogenesis Cancer Research ·Hoang Kieu Chi Ngo, Do‐Hee Kim, Young‐Nam Cha, Hye‐Kyung Na, Young‐Joon Surh	2017	71
9	Esculetin Suppresses Proliferation of Human Colon Cancer Cells by Directly Targeting β-Catenin Cancer Prevention Research ·Sungyoung Lee, Tae‐Gyu Lim, Hanyong Chen, Sung Keun Jung, Hyo‐Jeong Lee, Mee‐Hyun Lee, Dong Joon Kim, Aram Shin, Ki Won Lee, Ann M. Bode, Young‐Joon Surh, Zigang Dong	2013	62
10	Direct Targeting of MEK1/2 and RSK2 by Silybin Induces Cell-Cycle Arrest and Inhibits Melanoma Cell Growth Cancer Prevention Research ·Mee‐Hyun Lee, Zunnan Huang, Dong Joon Kim, Sung-Hyun Kim, Myoung Ok Kim, Sung‐Young Lee, Hua Xie, Si Jun Park, Jae Young Kim, Joydeb Kumar Kundu, Ann M. Bode, Young‐Joon Surh, Zigang Dong	2013	51
11	Zerumbone Induces Heme Oxygenase-1 Expression in Mouse Skin and Cultured Murine Epidermal Cells through Activation of Nrf2 Cancer Prevention Research ·Jun-Wan Shin, Kohta Ohnishi, Akira Murakami, Jeong‐Sang Lee, Joydeb Kumar Kundu, Hye-Kyung Na, Hajime Ohigashi, Young‐Joon Surh	2011	55
12	Multidrug Resistance-Associated Protein 1 Mediates 15-Deoxy-Δ^12,14-prostaglandin J₂-Induced Expression of Glutamate Cysteine Ligase Expression via Nrf2 Signaling in Human Breast Cancer Cells Chemical Research in Toxicology ·Na‐Young Song, Do‐Hee Kim, Eun‐Hee Kim, Hye‐Kyung Na, Nam‐Jung Kim, Young‐Ger Suh, Young‐Joon Surh	2011	23
13	Diallyl Trisulfide Inhibits Phorbol Ester–Induced Tumor Promotion, Activation of AP-1, and Expression of COX-2 in Mouse Skin by Blocking JNK and Akt Signaling Cancer Research ·Sangeeta Shrotriya, Joydeb Kumar Kundu, Hye‐Kyung Na, Young‐Joon Surh	2010	61
14	Resveratrol Suppresses Growth of Human Ovarian Cancer Cells in Culture and in a Murine Xenograft Model: Eukaryotic Elongation Factor 1A2 as a Potential Target Cancer Research ·Mee‐Hyun Lee, Bu Young Choi, Joydeb Kumar Kundu, Young Kee Shin, Hye-Kyung Na, Young‐Joon Surh	2009	65
15	Induction of Apoptosis in HT-29 Colon Cancer Cells by Phloretin Journal of Medicinal Food ·So Young Park, Eun Ji Kim, Hyun‐Kyung Shin, Dae Young Kwon, Myung‐Sunny Kim, Young‐Joon Surh, Jung Han Yoon Park	2007	48
16	Selenium Regulates Cyclooxygenase-2 and Extracellular Signal-Regulated Kinase Signaling Pathways by Activating AMP-Activated Protein Kinase in Colon Cancer Cells Cancer Research ·Jin‐Taek Hwang, Young‐Min Kim, Young‐Joon Surh, Haing Woon Baik, Seong‐Kyu Lee, Joohun Ha, Ock Jin Park	2006	89
17	Cancer chemopreventive ingredients in Asian foods(The 15th JEMS Annual Symposium"Strategy for Cancer Prevention by Foods : The Mechanisms of Antimutagenic and Anticarcinogenic Activities of Edible Plants") Young‐Joon Surh	2004	1
18	Cyclooxygenase-2 as a Molecular Target for Cancer Chemopreventive Agents Toxicological Research ·Young‐Joon Surh	2001	0
19	Anti-tumor-promoting activities of selected pungent phenolic substances present in ginger. PubMed ·Young‐Joon Surh, K K Park, Kyung‐Soo Chun, L J Lee, E Lee, S S Lee	1999	91
20	Cancer chemoprevention by dietary phytochemicals: a mechanistic viewpoint Seoul National University Open Repository (Seoul National University) ·Young‐Joon Surh	1998	18

About Young‐Joon Surh

Young‐Joon Surh is a scholar working on Geriatrics and Gerontology, Toxicology, Cancer Research, Molecular Medicine and Biochemistry, having authored 411 papers that have together received 27.8k indexed citations. Recurring topics across this work include Genomics, phytochemicals, and oxidative stress (133 papers), Inflammatory mediators and NSAID effects (60 papers), NF-κB Signaling Pathways (44 papers), Heme Oxygenase-1 and Carbon Monoxide (42 papers), Estrogen and related hormone effects (27 papers), Phytochemicals and Antioxidant Activities (27 papers), Sirtuins and Resveratrol in Medicine (27 papers) and Curcumin's Biomedical Applications (26 papers). The work is most often cited by research in Biochemistry (3.3k citations), Pharmacology (3.7k citations), Geriatrics and Gerontology (1.6k citations), Molecular Medicine (1.9k citations) and Toxicology (908 citations). Young‐Joon Surh has collaborated with scholars based in South Korea, United States and Puerto Rico. Frequent co-authors include Joydeb Kumar Kundu, Hye‐Kyung Na, Kyung‐Soo Chun, Young‐Nam Cha, Kwang-Kyun Park, Young‐Sam Keum, Do‐Hee Kim, Jeong‐Sang Lee, J. K. Kundu and Jung-Hee Jang. Their work appears in journals such as Cancer Letters, Biochemical Pharmacology, Annals of the New York Academy of Sciences, Carcinogenesis and Mutation research. Fundamental and molecular mechanisms of mutagenesis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact